NewAmsterdam Pharma N.V.
NAMS | NASDAQ
$23.41
+$0.83 (+3.68%)
Sep 22, 2026, 2:41 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.7M | 3.04M | 32K | 348K | 19.15M | 2.98M | 12.77M | 29.11M | 2.28M | 1.4M | 803K | 2.94M | 1.72M | 8.63M | 5.5M | 5.5M | 48.98M | 51.72M | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 500K | 59K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 3.7M | 2.54M | -27K | 348K | 19.15M | 2.98M | 12.77M | 29.11M | 2.28M | 1.4M | 803K | 2.94M | 1.72M | 8.63M | 5.5M | 5.5M | 48.98M | 51.72M | n/a | n/a | n/a | n/a |
Operating Income | -64.86M | -58.42M | -65.98M | -55.14M | -35.64M | -68.93M | -43.23M | -25M | -52.58M | -55.48M | -51.07M | -49.56M | -42.48M | -39.85M | -28.07M | -28.07M | 28.09M | 29.66M | -18.01M | -17.28M | -5.9M | -5.83M |
Interest Income | 5.81M | 4.04M | 6.47M | 6.71M | 7.06M | 7.35M | 4.49M | 4.44M | 4.87M | 3.08M | 2.52M | 2.75M | 4.23M | 869.35K | n/a | 707.21K | 102.85K | 13.12K | 2.92K | 1.78K | 7.02K | 4.45K |
Pretax Income | -64.14M | -48.44M | -74.92M | -72.01M | -17.36M | -39.53M | -92.18M | -16.65M | -39.01M | -93.77M | -49.47M | -47.13M | -38.29M | -42.02M | -38.04M | -38.04M | 28.56M | 30.15M | -20.13M | -11.07M | -5.62M | -5.56M |
Net Income | -64.14M | -48.44M | -74.92M | -72.01M | -17.36M | -39.53M | -92.18M | -16.65M | -39.01M | -93.77M | -49.5M | -47.13M | -38.29M | -42.02M | -38.04M | -38.04M | 28.56M | 30.15M | -20.13M | -11.07M | -5.62M | -5.56M |
Selling & General & Admin | 26.89M | 23.45M | 27.36M | 24.52M | 27.26M | 27.15M | 24.31M | 17.28M | 15.3M | 14.45M | 8.71M | 9.13M | 9.86M | 6.84M | 5.2M | 5.2M | 4.87M | 5.14M | 1.85M | 653.81K | 830.76K | 821.22K |
Research & Development | 41.67M | 37.51M | 38.59M | 30.97M | 27.52M | 44.75M | 34.9M | 35.7M | 38.38M | 42.43M | 41.29M | 43.37M | 34.34M | 40.42M | 28.37M | 28.37M | 16.02M | 16.92M | 9.88M | 9.54M | 5.07M | 5.01M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -3.21M | 1.14M | 1.18M | n/a | 1.88M | n/a | n/a | 1.23M | n/a | n/a | 1 | 1 | 6.28M | 7.08M | n/a | 1 |
Operating Expenses | 68.57M | 60.96M | 65.95M | 55.49M | 54.78M | 71.9M | 56M | 54.11M | 54.85M | 56.88M | 51.88M | 52.5M | 44.2M | 48.48M | 33.57M | 33.57M | 20.89M | 22.06M | 18.01M | 17.28M | 5.9M | 5.83M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.73M | 962.78K | 3.1M | 1.15M | 49.99K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -11.14M | 3.55M | 3.52M | n/a | 1.83M | 1.14M | 469K | 618K | 1.16M | 551.01K | 324.25K | 342.41K | 477.17K | 469.65K | 20.16K | 19.93K |
Cost & Expenses | 68.57M | 61.46M | 66.01M | 55.49M | 54.78M | 71.9M | 56M | 54.11M | 54.85M | 56.88M | 51.88M | 52.5M | 44.2M | 48.48M | 33.57M | 33.57M | 20.89M | 22.06M | 18.01M | 17.28M | 5.9M | 5.83M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | n/a | n/a | 27K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 123.37M | 121.1M | 114.4M | 119M | 112.51M | 116.12M | 97.03M | 94.75M | 94.71M | 82.16M | 82.48M | 82.48M | 81.85M | 81.63M | 18.36M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M |
Shares Outstanding (Diluted) | 123.37M | 121.1M | 114.4M | 119M | 112.51M | 116.12M | 97.03M | 94.75M | 94.71M | 82.16M | 82.48M | 82.48M | 81.85M | 81.63M | 18.36M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M |
EPS (Basic) | -0.52 | -0.40 | -0.65 | -0.61 | -0.15 | -0.34 | -0.98 | -0.18 | -0.41 | -1.06 | -0.52 | -0.56 | -0.43 | -0.47 | -2.20 | -23.19 | 0.75 | 0.75 | -1.73 | -0.82 | -0.43 | -0.43 |
EPS (Diluted) | -0.52 | -0.40 | -0.65 | -0.61 | -0.15 | -0.34 | -0.98 | -0.18 | -0.41 | -1.06 | -0.52 | -0.56 | -0.43 | -0.47 | -2.20 | -23.22 | 0.67 | 0.68 | -1.73 | -0.82 | -0.43 | -0.43 |
EBITDA | -59.69M | -48.38M | -74.86M | -71.94M | -17.32M | -39.48M | -111.69M | -23.84M | -51.38M | -93.75M | -50.99M | -46.16M | -35.18M | -38.62M | -37.99M | -38.04M | 28.57M | 30.17M | -12.35M | -11.51M | -5.9M | -5.83M |
EBIT | -59.78M | -48.44M | -74.92M | -72.01M | -17.36M | -39.53M | -111.74M | -23.87M | -51.4M | -93.77M | -51M | -46.17M | -35.19M | -38.63M | -37.99M | -38.04M | 28.56M | 30.15M | -12.35M | -11.51M | -5.9M | -5.83M |
Depreciation & Amortization | 89K | 62K | 59K | 64K | 45K | 52K | 51K | 28K | 19K | 15K | 13K | 14K | 13K | 9K | 2.25K | 7.38K | 18.86K | 19.91K | 1.59K | 1.16K | 1.19K | 1.17K |
Add to Watchlist
Select watchlists to add or remove NAMS